i+Med | i+Med | Drug products, Cosmetics, Nutraceutics & Medical Devices

About the Company

Founded in 2014, i+Med is a technology-based cooperative specializing in the research, development, and manufacturing of advanced biomedical technologies and controlled drug delivery systems.

Today, i+Med has established itself as a benchmark in smart biomaterials and personalized nanohydrogels, with a presence in international markets. Our essence defines us, but our commitment goes even further: to revolutionize personalized medicine through innovative solutions that enhance people s quality of life.

i+Med CDMO

CONTROLLED DRUG DELIVERY TECHNOLOGIES & SMART NANOHYDROGELS

• Smart hydrogels responsive to stimuli.
• Long-acting drug delivery systems for medical and cosmetic applications.
• Nanotechnology applied to drug administration.
• Development of customized formulations for various therapeutic areas.

BIOCOMPATIBILITY & NANOMEDICINE

• Biomimetic materials tailored to patient needs.
• Preclinical testing for biocompatibility validation.
• Clinical trials for product validation.
• Comprehensive project support, from formulation to product certification, with options for manufacturing or technology transfer.

PHARMACEUTICAL QUALITY & TECHNOLOGICAL CAPABILITIES

• State-of-the-art facilities with flexible manufacturing capacity.
• Development and production of biomaterials in compliance with international regulations.
• GMP certifications and European quality standards for the manufacturing of medical and cosmetic products.

COLLABORATION MODELS

Development

• Design and optimization of advanced formulations.
• Preclinical evaluation and biocompatibility characterization.
• GMP-compliant manufacturing for clinical trials.
• Small- and medium-scale production with a focus on flexibility and quality control.

Manufacturing

• Scalability assessment and process optimization.
• Large-scale production with technology transfer.
• Regulatory support and compliance assurance.
• Customized packaging and distribution solutions aligned with global standards.
• Ensuring product integrity from development to international distribution.

Biomaterials & Pharmaceutical Forms

• Long-acting injectable hydrogels.
• Functionalized nanohydrogels for targeted therapy.
• Advanced formulations for topical and ophthalmic use.
• Transdermal systems and controlled drug release technologies.
• Innovative medical devices tailored to patient needs.
• Finished Dosage Forms (FDF): PFS, Gel, Liquid, Oral, Cream, Drops, etc...